Overview
Early-stage venture capital firm investing in disruptive startups.
Founded
2022
Deals · 12mo
9
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Mendo
Participated · Series A · Jun 2026
Mendo offers a platform designed to help organisations identify practical AI use cases, encourage adoption across teams and maximise the value of AI initiatives. The company emphasizes bridging AI tools and employees to turn experimentation into measurable business outcomes, and it highlights agentic AI as a shift toward AI orchestrating operations. Early results cited by the company show adoption rates up to six times higher than traditional approaches. Mendo plans to strengthen analytics to better identify high-impact use cases and measure adoption. It also intends to double its headcount from roughly 50 to 100 employees, focusing hires in product, engineering and sales, and to accelerate commercial expansion across Europe. Mendo was founded in 2021.
- MokN
Participated · Series A · May 2026
MokN develops technology to detect and recover compromised identities, positioning itself in the emerging category it calls Active Identity Recovery. Its first product, Baits, deploys realistic decoy access points to reveal attackers using stolen credentials. The company says it currently protects more than one million users across large enterprises and mid-sized organisations. MokN plans upcoming products to secure customer accounts, stolen browser cookies and compromised sessions. Financially, it completed a €2.6 million seed round in October 2025 and has now raised $15 million in a Series A. The firm intends to invest the new capital in R&D, expand its product suite, and grow operations in France, the United States, and the United Kingdom.
- Lithosquare
Participated · Seed · May 2026
Lithosquare develops a Geology AI platform that combines artificial intelligence with geological expertise to accelerate discovery of copper, rare earths, and other critical metals. The company validated its technology by operating alongside initial exploration partners before announcing its seed raise. Following the $25 million seed financing, Lithosquare plans a global deployment of the platform and is actively hiring engineers and geologists to scale operations. The startup positions its product as a way to shorten conventional, capital-intensive exploration cycles and to improve the economics of discovery. Financially, the company has secured seed equity backing from institutional VC investors led by World Fund. No revenue, user, or valuation metrics were disclosed in the announcement.
- Piston
Participated · Seed · Mar 2026
Piston is developing what it calls an "Agentic ERP" designed for mid-market companies that build, make and move physical goods. The product aims to go beyond legacy ERPs by executing tasks (handling copy-paste between tools, processing quotes, managing orders, flagging stock issues and automating back-office work) rather than merely storing data. Piston emphasizes an AI-first architecture that enables faster deployment and continuous learning with users, addressing traditional ERP pain points like long scoping and configuration phases. The company positions itself as a third option for mid-size firms between stripped-down suites and disconnected tool stacks. Founders and core team members named in the announcement include Florian Bachelot, Eric Lacaille and Eugène Nélou, along with Cyril Lopez, Camille L., Benjamin Faucheux and Guillaume Jarry. The company intends to use seed funding to build out the platform and accelerate go-to-market, though no revenue, user metrics, or valuation were disclosed in the provided materials.
- baCta
Participated · Seed · Mar 2026
baCta develops baCtaForge, a strain-engineering platform that combines synthetic biology, robotics and generative AI to design microorganisms that efficiently produce industrial molecules. The system applies bio-based reinforcement learning to uncover genomic regions and regulatory pathways typically missed by conventional methods, cutting development time and cost. The company’s first commercial target is the antioxidant astaxanthin, whose production it is scaling from pilot to commercial volumes through a partnership with a French industrial player. By replacing petrochemical synthesis and limited natural extraction with precision fermentation, baCta addresses cost, seasonality and supply-chain risks in ingredient manufacturing. Proceeds from its latest financing will fund industrial scale-up, validation of manufacturing processes, and expansion of the baCtaForge platform to additional high-value molecules. Founded by Mathieu Nohet and Marie Rouquette, the company positions itself as an enabler of sustainable, large-scale bioproduction.